Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat

Diabetes

Volumn 46, Issue 3, 1997, Pages 335-341

  Wang, Qiong ^a   Bing, Chen ^a   Al Barazanji, Kamal ^b   Mossakowaska, Danuta E ^b   Wang, Xin Min ^b   McBay, Diane L ^b   Neville, William A ^b   Taddayon, Mohammad ^b   Pickavance, Lucy ^a   Dryden, Simon ^a   Thomas, Moira E A ^c   McHale, Mark T ^b   Gloyer, Israel S ^b   Wilson, Shelagh ^b   Buckingham, Robin ^b   Arch, Jonathan R S ^b   Trayhurn, Paul ^c   Williams, Gareth ^a,d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

^d Clinical Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y; RECOMBINANT PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; FOOD INTAKE; HYPOTHALAMUS; MALE; METABOLIC REGULATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; THALAMUS DORSOMEDIAL NUCLEUS; THALAMUS MIDLINE NUCLEUS;

EID: 14444268971     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.3.335     Document Type: Article

References (62)

1. Frankish HM, Dryden S, Hopkins D, Wang Q, Williams G: Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism. Peptides 164:757-771, 1995
2. Chronwall BM, Dimaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O'Donohue TL: The anatomy of neuropeptide Y containing neurons in the rat brain. J Neurosci 15:1159-1181, 1985
3. Stanley BG, Leibowitz SF: Neuropeptide Y injected into the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci USA 82:3940-3943, 1985
4. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF: NPY chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:1189-1192, 1986
5. Egawa M, Yoshimatsu H, Bray GA: Neuropeptide Y suppresses sympathetic activity to the intercapsular brown adipose tissue in rats. Am J Physiol 260:R328-R334, 1991
6. Billington CJ, Briggs JE, Grace G, Levine AS: Effects of intra-cerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 260:R321-R327, 1991
7. Abe M, Saito M, Shimazu T: Neuropeptide Y and noradrenalin injected into the paraventricular nucleus of the hypothalamus activate endocrine pancreas. Biomed Res 10:431-436, 1989
8. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B: Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133:1753-1758, 1993
9. Sanacora G, Kershaw M, Finklestein JA, White JD: Increased hypothalamic content of preproneuropeptide Y mRNA in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127:730-737, 1990
10. McKibbin PE, Cotton SJ, McMillan S, Holloway B, Mayers R, McCarthy HD, Williams G: Altered neuropeptide Y concentrations in specific hypothalamic regions of obese Zucker rats: possible relationship to obesity and neuroendocrine disturbances. Diabetes 40:1423-1429, 1991
11. Beck B, Burlet A, Nicolas JP, Burlet C: Hypothalamic neuropeptide Y in obese Zucker rats: implications in feeding and sexual behaviors. Physiol Behav 47:449-453, 1990
12. Dryden S, Pickavance L, Frankish HM, Williams G: Increased neuropeptide Y (NPY) secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res 690:185-188, 1995
13. McCarthy HD, McKibbin PE, Holloway B, Mayers R, Williams G: Hypothalamic neuropeptide Y receptor characteristics and NPY induced feeding responses in lean and obese Zucker rats. Life Sci 49:1491-1497, 1995
14. Dryden S, Frankish HM, Wang Q, Williams G: Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest 246:293-308, 1994
15. Jeanrenaud B: A hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 28:502-513, 1985
16. Wilding JPH, Gilbey SG, Bailey CJ, Batt RAL, Williams G, Ghatei MA, Bloom SR: Increased NPY mRNA and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132:1939-1944, 1993
17. Beck B, Uniyal M, Burlet A, Chapleur Chateau M, Leibowitz SF, Burlet C: Rapid and localised alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Res 528:245-249, 1990
18. Brady LS, Smith MA, Gold PW, Herkenham M: Altered expression of hypothalamic neuropeptide mRNAs in food restricted and food deprived rats Neuroendocrinology 52:441-447, 1990
19. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS: Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 88:10931-10935, 1991
20. Frankish, HM, McCarthy HD, Dryden S, Kilpatrick A, Williams G: Reduced hypothalamic neuropeptide Y receptor numbers in streptozocin diabetic and food deprived rats. Peptides 14:941-948, 1993
21. Williams G, Gill JS, Lee YC, Cardoso HM, Okper BE, Bloom SR: Increased neuropeptide Y concentrations in the specific hypothalamic regions of the streptozocin induced diabetic rats. Diabetes 38:321 327, 1989
22. White JU, Olchovsky D, Kershaw M, Berelowitz M: Increased hypothalamic content of pre-proneuropeptide Y mRNA in streptozocin diabetic rats. Endocrinology 126:765-772, 1990
23. Sahu A, Sninsky CA, Phelps CP, Dube MG, Kalra PS: Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozocin-induced diabetic rats. Endocrinology 131:2979-2985, 1992
24. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D: Insulin in the brain: a hormonal regulator of energy balance. Endocrin Rev 13:387-114, 1992
25. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurnik A, Kahn SE, Baskin DG: Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130:3608-3616, 1992
26. Akabayashi A, Watanabe Y, Wahlestedt C, McEwan BS, Paez X, Leibowitz SF: Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomised rats. Brain Res 665:201-212, 1994
27. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
28. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995
29. Halaas JL, Gajiwali KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
30. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995
31. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311, 1996
32. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhum P: Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 387:113-116, 1996
33. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin, and ob mRNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995
34. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR Jr, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530-532, 1995
35. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Fuster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS: Specificity of leptin action on elevated blood glucose and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531-535, 1996
36. Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B: The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats: reduced sensitivity compared with lean animals. Diabetes 45:1446-1450, 1996
37. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroenducrine response to fasting. Nature 382:250-252, 1996
38. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetolagia 39:353-356, 1996
39. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. 2nd ed. Sydney, Australia, Academic, 1986
40. Morris BJ: Neuronal localisation of neuropeptide Y gene expression in rat brain. J Comp Neurol 290:358-368, 1989
41. Chomczynski P, Sacchi N: Single step method for RNA isolation by acidguanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
42. Higuchi H, Yang HYT, Sabol SL: Rat neuropeptide Y precursor gene expression. J Biol Chem 263:6288-6295, 1988
43. Trayhurn P, Thomas MEA, Duncan JS, Black D, Beattie JH, Rayner DV: Ultrarapid detection of mRNAs on Northern blots with digoxigenin-labelled oligonucleotides and 'CDP-Star', a new chemiluminescence substrate. Biochem Soc 23:494, 1995
44. Trayhurn P, Duncan JS, Thomas MEA, Nestor A, Rayner DV: Chemiluminescent detection of mRNAs on Northern blots with digoxigenin end-labelled oligonucleotides. Anal Biochem 222:224-230, 1994
45. Trayhurn P, Duncan JS, Rayner DV: Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem J 311:729-733, 1995
46. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of leptin in fat regulation. Nature 380:677, 1996
47. Mrosovsky N: Body fat: what is regulated? Physiol Behav 38:407-414, 1986
48. Dryden S, Frankish HM, Wang Q, Pickavance L, Williams G: The serotonin (5-HT) antagonist methysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat. Brain Res 699:12-18, 1986
49. Bchini-Hooft Van Huijsduijnen O, Rohner-Jeanrenaud F, Jeanrenaud B: Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats: potential regulation thereof by corticotrophin-releasing factor. Neuroendocrinology 5:381-386, 1993
50. McCarthy HD, Dryden S, Williams G: Interleukin 1-induced anorexia and pyrexia in the rat: relationship to hypothalamic neuropeptide Y. Am J Physiol 269:E852-E857, 1995
51. Frankish HM, Dryden S, Wang Q, Bing C, MacFarlane IA, Williams G: Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Res 694:139-146, 1995
52. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS: Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy balance. Am J Physiol 266:R1765-R1770, 1994
53. Strack AM, Sebastian RJ, Schwartz MW, Dallan MF: Glucocorticoids and Insulin: reciprocal signals for energy balance. Am J Physiol 268:R142-R149, 1995
54. Cusin I, Dryden S, Wang Q, Rohner-Jeanrenaud F, Jeanrenaud B, Williams G: Effect of sustained physiological hyperinsulinemia on hypothalamic neuropeptide Y and NPY and mRNA levels in the rat. J Neuroendocrinol 7:193-197, 1995
55. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF: Acute and chronic effect of insulin on leptin production in humans. Diabetes 45:699-701, 1996
56. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: The ob gene and insulin. Diabetes 44:1467-1470, 1995
57. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Morgenstern JP: Evidence that the diabetes gene encoded the leptin receptor identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495, 1996
58. Chua SC, Chang WK, Wu-Peng XC, Zhang Y, Liu SM, Tartaglia L, Leibel RL: Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271:994-996, 1996
59. Schwartz MW, Peskin E, Raskind M, Boyko EJ, Porte D: Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med 2:587-593, 1996
60. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang P-L, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161, 1996
61. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF: The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 45:992-994, 1996
62. Erickson JC, Clegg KE, Palmiter RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-418, 1996